- Home
- RYTM vs OBDC Comparison
RYTM vs OBDC Comparison
Compare RYTM & OBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- OBDC
- Stock Information
- Founded
- RYTM 2008
- OBDC 2015
- Country
- RYTM United States
- OBDC United States
- Employees
- RYTM N/A
- OBDC N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- OBDC Investment Managers
- Sector
- RYTM Health Care
- OBDC Finance
- Exchange
- RYTM Nasdaq
- OBDC Nasdaq
- Market Cap
- RYTM 6.4B
- OBDC 7.2B
- IPO Year
- RYTM 2017
- OBDC 2019
- Fundamental
- Price
- RYTM $98.54
- OBDC $12.12
- Analyst Decision
- RYTM Strong Buy
- OBDC Buy
- Analyst Count
- RYTM 12
- OBDC 6
- Target Price
- RYTM $117.00
- OBDC $14.58
- AVG Volume (30 Days)
- RYTM 629.6K
- OBDC 5.2M
- Earning Date
- RYTM 11-04-2025
- OBDC 11-05-2025
- Dividend Yield
- RYTM N/A
- OBDC 12.97%
- EPS Growth
- RYTM N/A
- OBDC N/A
- EPS
- RYTM N/A
- OBDC 1.39
- Revenue
- RYTM $174,334,000.00
- OBDC $1,797,946,000.00
- Revenue This Year
- RYTM $46.10
- OBDC $19.55
- Revenue Next Year
- RYTM $63.02
- OBDC N/A
- P/E Ratio
- RYTM N/A
- OBDC $8.70
- Revenue Growth
- RYTM 54.92
- OBDC 11.43
- 52 Week Low
- RYTM $45.91
- OBDC $11.93
- 52 Week High
- RYTM $116.00
- OBDC $15.73
- Technical
- Relative Strength Index (RSI)
- RYTM 39.87
- OBDC 33.83
- Support Level
- RYTM $95.27
- OBDC $11.93
- Resistance Level
- RYTM $102.20
- OBDC $12.25
- Average True Range (ATR)
- RYTM 4.86
- OBDC 0.27
- MACD
- RYTM -1.75
- OBDC -0.08
- Stochastic Oscillator
- RYTM 17.51
- OBDC 11.99
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About OBDC Blue Owl Capital Corporation
Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.